Mingcan Yu Selected Research

starlicide

1/2019	IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
11/2015	IL-17A Is Increased in Humans with Primary Hyperparathyroidism and Mediates PTH-Induced Bone Loss in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mingcan Yu Research Topics

Disease

2	Bone Resorption 01/2020 - 01/2019
2	Primary Hyperparathyroidism 01/2019 - 11/2015
1	Osteoporosis 01/2018
1	Postmenopausal Osteoporosis 01/2016
1	Hyperparathyroidism 11/2015
1	Rheumatoid Arthritis 06/2012
1	Human Influenza (Influenza) 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 06/2010
1	Body Weight (Weight, Body) 11/2003

Drug/Important Bio-Agent (IBA)

2	starlicideIBA 01/2019 - 11/2015
2	Interleukin-17 (Interleukin 17)IBA 01/2019 - 11/2015
1	Parathyroid Hormone (Parathormone)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Teriparatide (Parathar)FDA Link 01/2018
1	LyasesIBA 01/2016
1	EnzymesIBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2015
1	AutoantigensIBA 06/2012
1	Immunoglobulin G (IgG)IBA 06/2012
1	Peptides (Polypeptides)IBA 06/2012
1	ras ProteinsIBA 06/2012
1	Proto-Oncogene Proteins B-rafIBA 06/2012
1	AutoantibodiesIBA 06/2012
1	CD40 Ligand (CD40L)IBA 04/2012
1	Interleukin-4 (Interleukin 4)IBA 04/2012
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2010
1	Male Contraceptive Agents (Male Contraceptives)IBA 11/2003

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 01/2016